Abstract:Background: Increased HBV-replication and/or intracellular HBsAgretention favor the onset of hepatocellular-carcinoma (HCC).Here, we define mutations in pre-S1/Pre-S2/S-gene correlated with HBVinduced HCC in-vivo, and investigate their impact on HBsAgretention and secretion in an in-vitro model.Methods: Sixty-seven HBV chronically-infected patients (74.6% genotype-D; 20.9% genotype-A; and 4.5% others), 19 of them with HCC and 48 asymptomatic patients (as control), were analyzed.Association of mutations with HCC was assessed by Fisher-test with Benjamini-Hochberg for multiple-comparison correction.Mutants were constructed by site-directed mutagenesis and expressed in HuH7-hepatocytes using the expression-vectors pCHD9 with fulllength HBV-genome (for mutations S98T S1 -P203Q S -S210R S ) and pCHsAgD with pre-S1/pre-S2/S-gene (for N40I S -K141N S ).After 72h quantitative-HBsAg was tested in cell-supernatants and in celllysates using Abbott-Architect assay.Results: Novel mutations in pre-S1 (S98T S1 ), and S region (N40I S -K141N S -P203Q S -S210R S ) correlate with HCC (P = 10 -2 to 10 -4 ) invivo.19/19 patients with HCC carry ≥1 of them (range-prevalence: 12.5% to 37.5%), while these mutations are absent (0/48 for N40I S ) or occurring with low frequency (1.9% for K141N S -P203Q S , 4.7% for S98T S1, 7.5% for S210R S ) in non-HCC patients.Strong correlations are observed for P203Q S +S210R S (phi=0.83)and N40I S +K141N S (phi=0.56).S98T S1 corresponds to the nucleotide codon 3175-3177 of HBVgenome localized in the promoter of the middle S-protein.In in-vitro experiments, its presence determines a 3.71 foldincrease in HBsAg-levels released in supernatants (S98T: 127.47[sd±53.45]IU/ml;WT: 34.40[sd±13.28]IU/ml,P = 0.00016).An opposite scenario is observed for P203Q S +S210R S , localized in the membrane-embedded C-terminal domain critical for HBsAg-secretion.This couple of mutations drastically decreases supernatant HBsAg-levels compared to P203Q and S210R alone, and to wild-type (P203Q+S210R: 9.42[sd±1.35]IU/ml;P203Q: 26.85[sd±13.01]IU/ml;S210R: 25.95[sd±8.82]IU/ml;WT: 34.40[sd:±13.28]IU/ml,P < 0.01).P203Q+S210R also decrease the ratio of supernatant to lysate HBsAg compared to wild-type (0.61 for P203Q+S210R versus 1.20 for wild-type), supporting their ability in inducing HBsAg intracellular-retention.Similarly, K141N determines a 52%-reduction of supernatant HBsAglevels compared to wild-type (K141N: 13.43[sd±9.68]IU/ml;WT: 28.25[sd±13.12]IU/ml.This reduction is greater when K141N is co-present with N40I (K141N+N40I: 4.67[sd±2.31]IU/ml,P = 0.012).K141N introduces a new N-linked glycosylation-site, while N40I resides in the cytosolic-loop involved in HBsAg-secretion.Conclusions: Key genetic-elements in pre-S1/pre-S2/S-gene correlate with HCC by inducing intracellular HBsAg-retention and/or by potentially altering the production of mRNAs for S-gene.Their detection may help identifying patients at higher HCC-risk.

Association between hepatitis B virus pre-S/S gene variants and HBV-related liver diseases

Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic B Patients

A study on sequence variations in preS/S regions of hepatitis B virus in occult infective patients

Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma

Pre-S Gene Mutation of Hepatitis B Virus and Its Biological Characteristics

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

Evolutionary Analysis of Pre-S/S Mutations in HBeAg-Negative Chronic Hepatitis B with HBsAg < 100 IU/ml

Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

Nucleotide variants in hepatitis B virus preS region predict the recurrence of hepatocellular carcinoma

Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen

Evolutionary analysis of pre S/S mutations in HBeAg-negative chronic hepatitis B with HBsAg <100 IU/ml

Association of variants in HLA - DP on chromosome 6 with chronic hepatitis B virus infection and related phenotypes

Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development

432 TRANSFER OF HEPATITIS B SURFACE MARKERS AND HBVDNA FROM HEPATITIS B SURFACE ANTIGEN POSITIVE MOTHERS TO THEIR OFFSPRING

Human Genetic Susceptibility to Hepatitis B Virus Infection.

The association of primary liver cancer with the mutations in basic core promoter and precore genes of hepatitis B virus

Association Of Hepatitis B Virus Pre-S Deletions With The Development Of Hepatocellular Carcinoma In Qidong, China

Sequence analysis of the Pre-S gene in chronic asymptomatic HBV carriers with low-level HBsAg

Study on the serology anomaly pattern of HBsAg and HBsAb positive at the same time of patients with HBV infection

HBV preS Mutations Promote Hepatocarcinogenesis by Inducing Endoplasmic Reticulum Stress and Upregulating Inflammatory Signaling

Relationship Between Genotypes and Mutations in S Gene Sequence of Chronic Hepatitis B Patients with Positive Results for Both HBsAg and HBsAb Tests